These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17588404)

  • 1. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
    Wittenstein B; Ng C; Ravn H; Goldman A
    Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
    Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
    Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
    Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
    Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?
    Warren OJ; Rogers PL; Watret AL; de Wit KL; Darzi AW; Gill R; Athanasiou T
    Pediatr Crit Care Med; 2009 Sep; 10(5):572-82. PubMed ID: 19451849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
    Gill R; Herbertson M; Vuylsteke A; Olsen PS; von Heymann C; Mythen M; Sellke F; Booth F; Schmidt TA
    Circulation; 2009 Jul; 120(1):21-7. PubMed ID: 19546387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery.
    Halkos ME; Levy JH; Chen E; Reddy VS; Lattouf OM; Guyton RA; Song HK
    Ann Thorac Surg; 2005 Apr; 79(4):1303-6. PubMed ID: 15797067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
    Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
    Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation.
    Kaliciński P; Markiewicz M; Kamiński A; Laniewski P; Ismail H; Drewniak T; Szymczak M; Nachulewicz P; Jezierska E
    Pediatr Transplant; 2005 Jun; 9(3):299-304. PubMed ID: 15910384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal membrane oxygenation for cardiac support in pediatric patients.
    Mehta U; Laks H; Sadeghi A; Marelli D; Odim J; Alejos J; Kim M; Atkinson JB; Bui KC
    Am Surg; 2000 Sep; 66(9):879-86. PubMed ID: 10993622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
    Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.